Literature DB >> 19123275

Decrease in the proportion of injecting drug use-related HIV/AIDS in Massachusetts, New York, Connecticut, and Rhode Island.

Jennifer A Mitty1, Lauri B Bazerman, Kyra Selwyn, Curt G Beckwith, Nickolas D Zaller, Josiah D Rich.   

Abstract

Injection drug use (IDU) has been a route for HIV transmission since the beginning of the epidemic. This review focuses on an apparent decrease in the proportion of IDU-related HIV/AIDS in Massachusetts, New York, Connecticut, and Rhode Island from 1999 to the present. Although there are differences in HIV/AIDS reporting requirements among these states, the dramatic reduction in the proportion of HIV and AIDS cases related to IDU is notable and is comparable to the 42% decline in HIV diagnoses among injection drug users reported by the CDC in other areas of the country.

Entities:  

Mesh:

Year:  2008        PMID: 19123275      PMCID: PMC2936235     

Source DB:  PubMed          Journal:  AIDS Read        ISSN: 1053-0894


  20 in total

1.  HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services.

Authors:  Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Lucia V Torian; Sara Beatrice; Judith Milliken; Donna Mildvan; Stanley Yancovitz; Samuel R Friedman
Journal:  Am J Public Health       Date:  2005-06-28       Impact factor: 9.308

2.  Sexual risk behaviors among substance users: relationship to impulsivity.

Authors:  Jumi Hayaki; Bradley Anderson; Michael Stein
Journal:  Psychol Addict Behav       Date:  2006-09

Review 3.  HIV prevention for injecting drug users: the first 25 years and counting.

Authors:  Don C Des Jarlais; Salaam Semaan
Journal:  Psychosom Med       Date:  2008-06-02       Impact factor: 4.312

4.  Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy.

Authors:  Amanda Mocroft; Jose Gatell; Peter Reiss; Bruno Ledergerber; Ole Kirk; Stefano Vella; Anders Blaxhult; Andrew N Phillips; Jens Lundgren
Journal:  AIDS       Date:  2004-11-19       Impact factor: 4.177

5.  Methamphetamine use and risky sexual behaviors during heterosexual encounters.

Authors:  William A Zule; Elizabeth C Costenbader; William J Meyer; Wendee M Wechsberg
Journal:  Sex Transm Dis       Date:  2007-09       Impact factor: 2.830

6.  An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction.

Authors:  H Masur; M A Michelis; J B Greene; I Onorato; R A Stouwe; R S Holzman; G Wormser; L Brettman; M Lange; H W Murray; S Cunningham-Rundles
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

7.  Stimulant use and sexual risk behaviors for HIV in rural North Carolina.

Authors:  William A Zule; Elizabeth Costenbader; Curtis M Coomes; William J Meyer; Kara Riehman; Jon Poehlman; Wendee M Wechsberg
Journal:  J Rural Health       Date:  2007       Impact factor: 4.333

8.  Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men.

Authors:  Grant Colfax; Eric Vittinghoff; Marla J Husnik; David McKirnan; Susan Buchbinder; Beryl Koblin; Connie Celum; Margaret Chesney; Yijian Huang; Kenneth Mayer; Sam Bozeman; Franklyn N Judson; Kendall J Bryant; Thomas J Coates
Journal:  Am J Epidemiol       Date:  2004-05-15       Impact factor: 4.897

Review 9.  Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview.

Authors:  France Lert; Michel D Kazatchkine
Journal:  Int J Drug Policy       Date:  2007-07-17

10.  A success story: HIV prevention for injection drug users in Rhode Island.

Authors:  Curt G Beckwith; Carla C Moreira; Hesham M Aboshady; Nickolas Zaller; Josiah D Rich; Timothy P Flanigan
Journal:  Subst Abuse Treat Prev Policy       Date:  2006-12-04
View more
  3 in total

1.  Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.

Authors:  Abby E Rudolph; Natalie D Crawford; Danielle C Ompad; Ebele O Benjamin; Rachel J Stern; Crystal M Fuller
Journal:  J Am Pharm Assoc (2003)       Date:  2010 Mar-Apr 1

2.  Associations between injection risk and community disadvantage among suburban injection drug users in southwestern Connecticut, USA.

Authors:  Robert Heimer; Russell Barbour; Wilson R Palacios; Lisa G Nichols; Lauretta E Grau
Journal:  AIDS Behav       Date:  2014-03

3.  Longitudinal typing of molecular HIV clusters in a statewide epidemic.

Authors:  Vlad Novitsky; Jon Steingrimsson; Mark Howison; Casey Dunn; Fizza S Gillani; Akarsh Manne; Yuanning Li; Matthew Spence; Zoanne Parillo; John Fulton; Theodore Marak; Philip Chan; Thomas Bertrand; Utpala Bandy; Nicole Alexander-Scott; Joseph Hogan; Rami Kantor
Journal:  AIDS       Date:  2021-09-01       Impact factor: 4.632

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.